In a patient with mild eosinophilia (absolute eosinophil count <1.5 × 10⁹/L) and no respiratory symptoms, should I refer them to pulmonology?

No, pulmonology referral is not indicated for mild eosinophilia without respiratory symptoms

In a patient with mild eosinophilia (AEC <1.5 × 10⁹/L) and no respiratory symptoms, pulmonology referral is not warranted. The evidence clearly demonstrates that mild eosinophilia in asymptomatic patients rarely represents clinically significant pulmonary disease and should be managed through alternative pathways.

Rationale Based on Evidence Hierarchy

Threshold for Specialist Referral

The most recent hematology data from 2026 establishes that an AEC threshold of 1.5 × 10⁹/L has 97% sensitivity for clinically meaningful eosinophilia requiring specialist intervention 1. Your patient falls below this threshold, making specialist referral premature.

The 2025 UK guidelines for eosinophilia management specify that hematology referral should be considered only when eosinophilia ≥1.5 × 10⁹/L persists for more than 3 months after infectious causes have been excluded or treated 2. This applies to hematology, not pulmonology, and only after prolonged persistence.

Clinical Significance of Mild Eosinophilia Without Symptoms

Research demonstrates that mild eosinophilia (<1.5 × 10⁹/L) is mainly associated with airway disease when pulmonary involvement exists 3. Without respiratory symptoms, the likelihood of significant pulmonary pathology is extremely low.

The 2026 parasitology data reveals that most parasitic infections causing eosinophilia present with mild-to-moderate elevations 4, but these patients typically have accompanying symptoms. Asymptomatic mild eosinophilia more commonly reflects:

• Allergic conditions (asthma, eczema, hay fever)
• Drug reactions
• Atopy
• Incidental findings 2

When Pulmonology Becomes Relevant

Pulmonology referral becomes appropriate when:

Respiratory symptoms develop, including:

• Chronic cough
• Dyspnea
• Wheezing
• Hemoptysis
• Chest pain 3, 5, 6

Radiographic abnormalities appear, such as:

• Pulmonary infiltrates
• Consolidations
• Pleural effusions
• Cavitary lesions 2, 3

Eosinophilia becomes severe (≥5.0 × 10⁹/L), which is associated with:

• Extrapulmonary organ involvement
• Constitutional symptoms
• Cardiac, pleural, or skin manifestations
• Risk of end-organ damage 3, 2

Recommended Management Pathway

For your asymptomatic patient with mild eosinophilia:

1. Investigate common non-pulmonary causes first:

   • Detailed medication history (drug-induced eosinophilia)
   • Allergy/atopy assessment
   • Travel history (helminth exposure in returning travelers/migrants)
   • Autoimmune screening if clinically indicated 2

2. Consider infectious workup if epidemiologically appropriate:

   • Helminth serology if travel to endemic areas
   • Stool microscopy for parasites (though sensitivity is low)
   • The 2025 guidelines emphasize that helminths are the commonest identifiable cause in travelers/migrants 2

3. Monitor and reassess:

   • Repeat CBC in 3-6 months
   • Refer to hematology (not pulmonology) only if eosinophilia ≥1.5 × 10⁹/L persists beyond 3 months 2

4. Urgent evaluation only if:

   • Evidence of end-organ damage develops
   • Constitutional symptoms emerge
   • AEC rises to severe levels (≥5.0 × 10⁹/L) 2, 3

Critical Pitfall to Avoid

Do not reflexively refer asymptomatic mild eosinophilia to subspecialists. The 2026 hematology study specifically addresses this issue, demonstrating that 44.8% of referred eosinophilia cases were ultimately deemed idiopathic, and many referrals were unnecessary 1. Premature subspecialty referral leads to:

• Healthcare resource waste
• Patient anxiety
• Unnecessary invasive procedures
• Delayed identification of actual underlying causes

The evidence supports a measured, systematic primary care approach for mild asymptomatic eosinophilia, reserving pulmonology consultation for patients who develop respiratory manifestations or meet higher-risk criteria.